Prader-Will Syndrome Epidemiology Forecast to 2030

Prader-Will Syndrome Epidemiology Forecast to 2030

Delveinsight Business Research
DelveInsight’s ‘Prader-Will Syndrome Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Prader-Will Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

According to US National Library of Medicine, Prader-Willi syndrome is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. Some people with Prader-Willi syndrome, particularly those with obesity, also develop type 2 diabetes (the most common form of diabetes).

The disease occurs due to the loss of function of several genes in a particular region of chromosome number 15. Among these are genes that provide instructions for making molecules called small nucleolar RNAs (snoRNAs).

According to NORD, Prader-Will Syndrome (PWS) is the first syndromic form of neurodevelopmental disorder that was confirmed to be caused due to imprinting errors leading to a genetic multisystem disorder characterized during infancy by lethargy, diminished muscle tone (hypotonia), feeding difficulties, poor weight gain and growth hormone deficiency. Although considered a “rare” disorder, PWS is one of the most common conditions seen in genetic clinics and is the most common genetic cause of obesity that has been identified to date.

The DelveInsight Prader-Will Syndrome epidemiology report gives a thorough understanding of the Prader-Will Syndrome by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. 

It also provides treatment algorithms and treatment guidelines for Prader-Will Syndrome in the US, Europe, and Japan. The report covers the detailed information of the Prader-Will Syndrome epidemiology scenario in seven major countries (US, EU5, and Japan).


Key Highlights Of The Report

  • As per the Foundation for PWS Research, the disease occurs in approximately one out of every 15,000 births.

  • It affects males and females with equal frequency and affects all races and ethnicities

  • According to DelveInsight’s estimation, the total prevalent cases of Prader Willi syndrome (PWS) were found to be around 47,000 for 7 Major Markets in the year 2017

 Prader-Will Syndrome Epidemiology

Request for Sample Pages:


Prader-Will Syndrome Epidemiology

Delveinsight’s Prader-Will Syndrome epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. 

The Prader-Will Syndrome epidemiology data are studied through all possible divisions to give a better understanding of the Disease scenario in 7MM. 

The Prader-Will Syndrome epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. 

It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Scope of the Report

  • The report provides insight into the historical and forecasted patient pool of Prader-Will Syndrome in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

  • The report assesses the disease risk and burden and highlights the unmet needs of Prader-Will Syndrome.

  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.

  • The Prader-Will Syndrome report provides a detailed overview explaining Prader-Will Syndrome causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns.

  • The Prader-Will Syndrome Epidemiology Report and Model provide an overview of the risk factors and global trends of Prader-Will Syndrome in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan).

  • The report provides the segmentation of the Prader-Will Syndrome epidemiology. 

Key Questions Covered In The Prader-Will Syndrome Report Include:

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Prader-Will Syndrome?

  • What are the key findings pertaining to the Prader-Will Syndrome epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?

  • What would be the total number of patients of Prader-Will Syndrome across the 7MM during the forecast period (2017-2030)?

  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?

  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?

  • What is the disease risk, burden and unmet needs of the Prader-Will Syndrome?

  • What are the currently available treatments of Prader-Will Syndrome?


Key Benefit of Prader-Will Syndrome Epidemiology Report 

  • The Prader-Will Syndrome Epidemiology report will allow the user to –

  • Develop business strategies by understanding the trends shaping and driving the global Prader-Will Syndrome market

  • Quantify patient populations in the global Prader-Will Syndrome market to improve product design, pricing, and launch plans

  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Prader-Will Syndrome therapeutics in each of the markets covered

  • Understand the magnitude of Prader-Will Syndrome population by its epidemiology

  • The Prader-Will Syndrome Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Table of Contents

  1. Key Insights 

  2. Executive Summary of Prader-Will Syndrome

  3. Prader-Will Syndrome Disease Background and Overview

  • Prader-Will Syndrome Sign and Symptoms

  • Prader-Will Syndrome Pathophysiology

  • Prader-Will Syndrome Risk Factors

  • Prader-Will Syndrome Diagnosis

  1. Prader-Will Syndrome Patient Journey

  2. Prader-Will Syndrome Epidemiology and Patient Population

  3. Prader-Will Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

  4. KOL Views on Prader-Will Syndrome 

  5. Prader-Will Syndrome Unmet Needs

  6. Appendix

  7. DelveInsight Capabilities

  8. Disclaimer

*The table of contents is not exhaustive; will be provided in the final report


About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.


Related Reports:

Prader-Willi Syndrome Market Insight, Epidemiology and Market Forecast 2030

DelveInsight’ s Prader-Willi Syndrome Market Insights, Epidemiology and Market Forecast  2030 report provides a detailed overview of the disease and in-depth understanding of historical and forecasted epidemiology.


Prader-Willi Syndrome Pipeline Insights, 2020

Prader-Willi Syndrome Pipeline Insight, 2020 report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Prader-Willi Syndrome market.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States